All AbMole products are for research use only, cannot be used for human consumption.
TIC10 (ONC-201) is a potent, orally active, and stable small molecule that transcriptionally induces TRAIL in a p53-independent manner and crosses the blood-brain barrier. TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior compound properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics.
Carcinogenesis. 2019 May 29.
Extracellular Vesicles-Derived OncomiRs Mediate Communication between Cancer Cells and Cancer-Associated Hepatic Stellate Cells in Hepatocellular Carcinoma Microenvironment.
TIC10 purchased from AbMole
 |
Source | Cancer Med (2017). Figure 1. TIC10 |
| Method | western blotting | |
| Cell Lines | MPM cell lines | |
| Concentrations | 50 or 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, and 0.01 μmol/L | |
| Incubation Time | 48 h | |
| Results | In contrast, the expression and phosphorylation levels of PI3K/p85, which negatively regulates the catalytic activity of p110α, were negligible in the MPM cell lines except for NCI-H28, whereas only total PI3K/p85 was detected in normal mesothelial cell line MeT-5A |
| Cell Experiment | |
|---|---|
| Cell lines | HCT116 cells |
| Preparation method | Ability of TIC10 (5 μM) or TRAIL (25 ng/ml) to reduce cell viability in HCT116 cells after a 1-hour preincubation at the indicated temperatures (72 hours, n = 3). |
| Concentrations | 5 μM |
| Incubation time | - |
| Animal Experiment | |
|---|---|
| Animal models | Female athymic nu/nu mice |
| Formulation | DMSO |
| Dosages | 25, 50, 100 mg/kg |
| Administration | Intraperitoneal/oral |
| Molecular Weight | 386.49 |
| Formula | C24H26N4O |
| CAS Number | 1616632-77-9 |
| Solubility (25°C) | DMSO: ≥ 12 mg/mL (Need warming) |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Akt Products |
|---|
| AT7867
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase with an IC50 of 17 nM. |
| GSK690693
GSK690693 is a potent Akt inhibitor (Akt1 IC50 = 2 nM, Akt2 IC50 = 13 nM, Akt3 IC50 = 9 nM) which also inhibited the phosphorylation of the downstream target GSK3b in cells. |
| Perifosine
Perifosine is an orally active Akt inhibitor, the antiproliferative properties of Perifosine with an IC50 of 0.6–8.9 µM. |
| MK-2206 2HCl
MK-2206 is a novel allosteric inhibitor of Akt with IC50 values of 8 nM, 12 nM and 65 nM for Akt1, Akt2 and Akt3, respectively. |
| Ipatasertib
Ipatasertib (GDC-0068, RG7440) is a potent and selective, ATP-competitive Akt inhibitor with IC50 values of 5 to 18 nM. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
